Precigen (PGEN) Gains from Investment Securities (2016 - 2025)
Precigen (PGEN) has disclosed Gains from Investment Securities for 12 consecutive years, with $1.3 million as the latest value for Q2 2025.
- On a quarterly basis, Gains from Investment Securities changed N/A to $1.3 million in Q2 2025 year-over-year; TTM through Sep 2025 was $1.8 million, a 177500.0% increase, with the full-year FY2023 number at -$2000.0, up 98.13% from a year prior.
- Gains from Investment Securities was $1.3 million for Q2 2025 at Precigen, up from $474000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.3 million in Q2 2025 to a low of -$105000.0 in Q2 2022.
- A 4-year average of $182666.7 and a median of -$1000.0 in 2021 define the central range for Gains from Investment Securities.
- Peak YoY movement for Gains from Investment Securities: skyrocketed 91.67% in 2022, then surged 150.0% in 2023.
- Precigen's Gains from Investment Securities stood at -$24000.0 in 2021, then surged by 91.67% to -$2000.0 in 2022, then soared by 150.0% to $1000.0 in 2023, then soared by 130100.0% to $1.3 million in 2025.
- Per Business Quant, the three most recent readings for PGEN's Gains from Investment Securities are $1.3 million (Q2 2025), $474000.0 (Q1 2025), and $1000.0 (Q4 2023).